GHRL and amyotrophic lateral sclerosis: Among them, WO2014065341A1 proposed ghrelin or its mimetics as therapeutic agents for the treatment of ALS, in combination with current therapies, in patients that do not exhibit severe dysphagia and are insufficiently responsive to existing therapeutic agents for ALS.